June 2012 Editor's Picks: Products from EMD Millipore and Meissner Filtration Products - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

June 2012 Editor's Picks: Products from EMD Millipore and Meissner Filtration Products

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

EMD Millipore
Single-use bioreactor is designed for process development or pilot-scale cell culture

EMD Millipore’s Mobius CellReady 50-L single-use, stirred tank bioreactor is designed for process development and pilot-scale mammalian cell culture. The rigid base and top panel design of the bioreactor process container enables simple, reliable, and robust one-way installation. Mobius SensorReady technology allows the user to configure process monitoring at the point of use and enables integration of new sensor technologies. The system is available as a turnkey solution complete with Finesse automation or as modules that can be integrated with the customer’s platform of choice.


Meissner Filtration Products
Containers support disposable biocontainer assemblies

Meissner Filtration Products’ QuaDrum containers for Meissner’s TepoFlex 3D biocontainer assemblies have a square design rather than the industry standard cylindrical design.  The design makes efficient use of floor space, and can be used with a stainless steel dolly for intra-facility transport. The reusable, polyethylene containers are chemically resistant and can be sanitized. Slotted lids offer access to tubing and filters or solid lids completely cover the assembly.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
11%
Protecting the supply chain
39%
Expedited reviews of drug submissions
11%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Equipment and Processing Report,
Click here